Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding Site
暂无分享,去创建一个
Stefan Knapp | Eric D. Scheeff | Gerard Manning | S. Knapp | E. Scheeff | G. Manning | J. Eswaran | Gabor Bunkoczi | G. Bunkoczi | Jeyanthy Eswaran
[1] T. Südhof,et al. CASK Functions as a Mg2+-Independent Neurexin Kinase , 2008, Cell.
[2] R. Huber,et al. Phosphotransferase and substrate binding mechanism of the cAMP‐dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5‐24). , 1993, The EMBO journal.
[3] Andreas Prlic,et al. Ensembl 2007 , 2006, Nucleic Acids Res..
[4] R. Nichols,et al. Characterization of Three Paralogous Members of the Mammalian Vaccinia Related Kinase Family* , 2004, Journal of Biological Chemistry.
[5] Ana Sevilla,et al. p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1 , 2004, Molecular and Cellular Biology.
[6] G. Barton,et al. Emerging roles of pseudokinases. , 2006, Trends in cell biology.
[7] G. Crooks,et al. WebLogo: a sequence logo generator. , 2004, Genome research.
[8] Claudio R. Santos,et al. Modulation of Interleukin-1 Transcriptional Response by the Interaction between VRK2 and the JIP1 Scaffold Protein , 2008, PloS one.
[9] F. Collart,et al. A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. , 2002, Protein expression and purification.
[10] S. Kimura,et al. Autophosphorylation of β-connectin (titin 2) in vitro , 1992 .
[11] Kyong-Tai Kim,et al. Mitotic Histone H3 Phosphorylation by Vaccinia-Related Kinase 1 in Mammalian Cells , 2007, Molecular and Cellular Biology.
[12] R. Durbin,et al. GeneWise and Genomewise. , 2004, Genome research.
[13] J. Nezu,et al. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. , 1997, Genomics.
[14] W. Gullick,et al. Identification of c‐erbB‐3 binding sites for phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera. , 1994, The EMBO journal.
[15] Kyong-Tai Kim,et al. VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues. , 2008, Biochimica et biophysica acta.
[16] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Lynn F. Ten Eyck,et al. A helix scaffold for the assembly of active protein kinases , 2008, Proceedings of the National Academy of Sciences.
[18] T. Hunter,et al. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[20] Itay Mayrose,et al. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures , 2005, Nucleic Acids Res..
[21] W. Kolch. Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.
[22] P. Lazo,et al. Human VRK1 Is an Early Response Gene and Its Loss Causes a Block in Cell Cycle Progression , 2008, PloS one.
[23] Gerard Manning,et al. Structural and Functional Diversity of the Microbial Kinome , 2007, PLoS biology.
[24] A. Sevilla,et al. Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations. , 2007, Archives of biochemistry and biophysics.
[25] Claudio R. Santos,et al. Vaccinia-Related Kinase 2 Modulates the Stress Response to Hypoxia Mediated by TAK1 , 2007, Molecular and Cellular Biology.
[26] T. Hunter,et al. Evolution of protein kinase signaling from yeast to man. , 2002, Trends in biochemical sciences.
[27] K. Longenecker,et al. Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition. , 1996, Journal of molecular biology.
[28] D. Morrison,et al. KSR: a MAPK scaffold of the Ras pathway? , 2001, Journal of cell science.
[29] Susan S. Taylor,et al. Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.
[30] C. Gibbs,et al. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. , 1991, The Journal of biological chemistry.
[31] J. Adams,et al. Nucleotide-induced conformational changes in the Saccharomyces cerevisiae SR protein kinase, Sky1p, revealed by X-ray crystallography. , 2003, Biochemistry.
[32] David L. Wheeler,et al. GenBank , 2015, Nucleic Acids Res..
[33] Chung F. Wong,et al. The structure of Sky1p reveals a novel mechanism for constitutive activity , 2001, Nature Structural Biology.
[34] Liisa Holm,et al. DaliLite workbench for protein structure comparison , 2000, Bioinform..
[35] R. Russell,et al. Functional Analysis of H-Ryk, an Atypical Member of the Receptor Tyrosine Kinase Family , 1999, Molecular and Cellular Biology.
[36] Daumantas Matulis,et al. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. , 2005, Biochemistry.
[37] Kathleen A. Boyle,et al. Mutant Defective in the B 1 Kinase ts Virus DNA-Negative Phenotype of a Vaccinia Protein Kinases Complement the Members of a Novel Family of Mammalian , 2004 .
[38] H. Shih,et al. Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival. , 2006, The Journal of general virology.
[39] S. Knapp,et al. Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. , 2005, Journal of medicinal chemistry.
[40] R M Sweet,et al. Crystal structure of casein kinase‐1, a phosphate‐directed protein kinase. , 1995, The EMBO journal.
[41] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[42] A. Prescott,et al. Analysis of the LKB1-STRAD-MO25 complex , 2004, Journal of Cell Science.
[43] R. Steele,et al. Deceiving appearances: signaling by “dead” and “fractured” receptor protein‐tyrosine kinases , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[44] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[45] L. Berg,et al. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. , 1996, Oncogene.
[46] Philip E. Bourne,et al. Structural Evolution of the Protein Kinase–Like Superfamily , 2005, PLoS Comput. Biol..
[47] Paul Young,et al. Structural basis for activation of the titin kinase domain during myofibrillogenesis , 1998, Nature.
[48] Jack Snoeyink,et al. Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .
[49] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[50] J. Kuriyan,et al. The Conformational Plasticity of Protein Kinases , 2002, Cell.
[51] Jonathan Bard,et al. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. , 2004, Analytical biochemistry.
[52] A. R. Shenoy,et al. The kinase homology domain of receptor guanylyl cyclase C: ATP binding and identification of an adenine nucleotide sensitive site. , 2006, Biochemistry.
[53] P. Lazo,et al. Proteomics Identification of Nuclear Ran GTPase as an Inhibitor of Human VRK1 and VRK2 (Vaccinia-related Kinase) Activities , 2008, Molecular & Cellular Proteomics.
[54] P. Lazo,et al. The subcellular localization of vaccinia‐related kinase‐2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines , 2006, The FEBS journal.
[55] Kyong-Tai Kim,et al. Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase , 2006, Nature Cell Biology.
[56] Claudio R. Santos,et al. Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK* , 2004, Journal of Biological Chemistry.
[57] Susan S. Taylor,et al. Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.
[58] Wolfgang Kabsch,et al. Integration, scaling, space‐group assignment and post refinement , 2006 .
[59] Susan S. Taylor,et al. Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase , 2002, Nature Structural Biology.
[60] R. Nichols,et al. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. , 2006, Molecular biology of the cell.
[61] D. Bossemeyer,et al. The glycine-rich sequence of protein kinases: a multifunctional element. , 1994, Trends in biochemical sciences.
[62] P. Lazo,et al. Expression of the VRK (vaccinia‐related kinase) gene family of p53 regulators in murine hematopoietic development , 2003, FEBS letters.
[63] S. Taylor,et al. Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase. , 1998, Biochemistry.
[64] T. Hunter,et al. Signaling—2000 and Beyond , 2000, Cell.
[65] P. Lazo,et al. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein , 2000, Oncogene.
[66] Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. , 2004, Structure.